nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Dermatitis perioral—Tretinoin—peripheral nervous system neoplasm	0.02	0.0201	CcSEcCtD
Desonide—Dermatitis perioral—Isotretinoin—peripheral nervous system neoplasm	0.02	0.0201	CcSEcCtD
Desonide—Telangiectasia—Tretinoin—peripheral nervous system neoplasm	0.0192	0.0193	CcSEcCtD
Desonide—Application site erythema—Isotretinoin—peripheral nervous system neoplasm	0.0192	0.0193	CcSEcCtD
Desonide—Telangiectasia—Isotretinoin—peripheral nervous system neoplasm	0.0192	0.0193	CcSEcCtD
Desonide—Application site erythema—Tretinoin—peripheral nervous system neoplasm	0.0192	0.0193	CcSEcCtD
Desonide—Application site pruritus—Tretinoin—peripheral nervous system neoplasm	0.0186	0.0187	CcSEcCtD
Desonide—Application site pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0186	0.0187	CcSEcCtD
Desonide—Acneiform eruption—Tretinoin—peripheral nervous system neoplasm	0.0179	0.018	CcSEcCtD
Desonide—Acneiform eruption—Isotretinoin—peripheral nervous system neoplasm	0.0179	0.018	CcSEcCtD
Desonide—Application site rash—Alitretinoin—peripheral nervous system neoplasm	0.0157	0.0158	CcSEcCtD
Desonide—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0154	0.0155	CcSEcCtD
Desonide—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0154	0.0155	CcSEcCtD
Desonide—Miliaria—Isotretinoin—peripheral nervous system neoplasm	0.0154	0.0155	CcSEcCtD
Desonide—Miliaria—Tretinoin—peripheral nervous system neoplasm	0.0154	0.0155	CcSEcCtD
Desonide—Dermatitis perioral—Alitretinoin—peripheral nervous system neoplasm	0.0151	0.0152	CcSEcCtD
Desonide—Skin atrophy—Tretinoin—peripheral nervous system neoplasm	0.015	0.0151	CcSEcCtD
Desonide—Skin atrophy—Isotretinoin—peripheral nervous system neoplasm	0.015	0.0151	CcSEcCtD
Desonide—Telangiectasia—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Desonide—Application site erythema—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Desonide—Skin striae—Tretinoin—peripheral nervous system neoplasm	0.0142	0.0143	CcSEcCtD
Desonide—Skin striae—Isotretinoin—peripheral nervous system neoplasm	0.0142	0.0143	CcSEcCtD
Desonide—Application site pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0141	0.0141	CcSEcCtD
Desonide—Acneiform eruption—Alitretinoin—peripheral nervous system neoplasm	0.0136	0.0137	CcSEcCtD
Desonide—Dermatitis acneiform—Tretinoin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Desonide—Dermatitis acneiform—Isotretinoin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Desonide—Allergic contact dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Desonide—Allergic contact dermatitis—Tretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Desonide—Miliaria—Alitretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Desonide—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Desonide—Skin atrophy—Alitretinoin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Desonide—Skin striae—Alitretinoin—peripheral nervous system neoplasm	0.0108	0.0109	CcSEcCtD
Desonide—Leukoderma—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Desonide—Leukoderma—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Desonide—Application site pain—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0104	CcSEcCtD
Desonide—Application site pain—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0104	CcSEcCtD
Desonide—Dermatitis acneiform—Alitretinoin—peripheral nervous system neoplasm	0.01	0.0101	CcSEcCtD
Desonide—Allergic contact dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00982	0.00988	CcSEcCtD
Desonide—Application site reaction—Tretinoin—peripheral nervous system neoplasm	0.00966	0.00971	CcSEcCtD
Desonide—Application site reaction—Isotretinoin—peripheral nervous system neoplasm	0.00966	0.00971	CcSEcCtD
Desonide—Leukoderma—Alitretinoin—peripheral nervous system neoplasm	0.00807	0.00812	CcSEcCtD
Desonide—Application site pain—Alitretinoin—peripheral nervous system neoplasm	0.0078	0.00785	CcSEcCtD
Desonide—Application site reaction—Alitretinoin—peripheral nervous system neoplasm	0.00732	0.00736	CcSEcCtD
Desonide—Folliculitis—Tretinoin—peripheral nervous system neoplasm	0.00721	0.00725	CcSEcCtD
Desonide—Folliculitis—Isotretinoin—peripheral nervous system neoplasm	0.00721	0.00725	CcSEcCtD
Desonide—Induration—Etoposide—peripheral nervous system neoplasm	0.00599	0.00602	CcSEcCtD
Desonide—Folliculitis—Dactinomycin—peripheral nervous system neoplasm	0.00589	0.00592	CcSEcCtD
Desonide—Rash pustular—Tretinoin—peripheral nervous system neoplasm	0.00568	0.00571	CcSEcCtD
Desonide—Rash pustular—Isotretinoin—peripheral nervous system neoplasm	0.00568	0.00571	CcSEcCtD
Desonide—Stinging—Tretinoin—peripheral nervous system neoplasm	0.00559	0.00562	CcSEcCtD
Desonide—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.00559	0.00562	CcSEcCtD
Desonide—Folliculitis—Alitretinoin—peripheral nervous system neoplasm	0.00546	0.00549	CcSEcCtD
Desonide—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.00511	0.00514	CcSEcCtD
Desonide—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.00473	0.00475	CcSEcCtD
Desonide—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.00448	0.0045	CcSEcCtD
Desonide—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.00448	0.0045	CcSEcCtD
Desonide—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00435	CcSEcCtD
Desonide—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00435	CcSEcCtD
Desonide—Rash pustular—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.00433	CcSEcCtD
Desonide—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.00427	0.00429	CcSEcCtD
Desonide—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00424	0.00426	CcSEcCtD
Desonide—Leukoderma—Epirubicin—peripheral nervous system neoplasm	0.00353	0.00355	CcSEcCtD
Desonide—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.00339	0.00341	CcSEcCtD
Desonide—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00329	CcSEcCtD
Desonide—Leukoderma—Doxorubicin—peripheral nervous system neoplasm	0.00327	0.00329	CcSEcCtD
Desonide—Irritability—Tretinoin—peripheral nervous system neoplasm	0.00314	0.00316	CcSEcCtD
Desonide—Irritability—Isotretinoin—peripheral nervous system neoplasm	0.00314	0.00316	CcSEcCtD
Desonide—Asthma—Tretinoin—peripheral nervous system neoplasm	0.00284	0.00286	CcSEcCtD
Desonide—Asthma—Isotretinoin—peripheral nervous system neoplasm	0.00284	0.00286	CcSEcCtD
Desonide—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.00279	0.00281	CcSEcCtD
Desonide—Upper respiratory tract infection—Tretinoin—peripheral nervous system neoplasm	0.00264	0.00266	CcSEcCtD
Desonide—Upper respiratory tract infection—Isotretinoin—peripheral nervous system neoplasm	0.00264	0.00266	CcSEcCtD
Desonide—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.00256	0.00257	CcSEcCtD
Desonide—Infestation NOS—Topotecan—peripheral nervous system neoplasm	0.00255	0.00257	CcSEcCtD
Desonide—Infestation—Topotecan—peripheral nervous system neoplasm	0.00255	0.00257	CcSEcCtD
Desonide—Infestation NOS—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00255	CcSEcCtD
Desonide—Infestation NOS—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00255	CcSEcCtD
Desonide—Infestation—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00255	CcSEcCtD
Desonide—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00255	CcSEcCtD
Desonide—Sweating—Topotecan—peripheral nervous system neoplasm	0.00245	0.00246	CcSEcCtD
Desonide—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00244	CcSEcCtD
Desonide—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00244	CcSEcCtD
Desonide—Folliculitis—Epirubicin—peripheral nervous system neoplasm	0.00239	0.0024	CcSEcCtD
Desonide—Irritability—Alitretinoin—peripheral nervous system neoplasm	0.00238	0.00239	CcSEcCtD
Desonide—Pharyngitis—Topotecan—peripheral nervous system neoplasm	0.00228	0.00229	CcSEcCtD
Desonide—Pharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00226	0.00227	CcSEcCtD
Desonide—Pharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00226	0.00227	CcSEcCtD
Desonide—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00225	CcSEcCtD
Desonide—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00225	CcSEcCtD
Desonide—Folliculitis—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00222	CcSEcCtD
Desonide—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00217	CcSEcCtD
Desonide—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.00207	0.00208	CcSEcCtD
Desonide—Irritability—Cisplatin—peripheral nervous system neoplasm	0.00203	0.00204	CcSEcCtD
Desonide—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.00202	0.00203	CcSEcCtD
Desonide—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.002	0.00201	CcSEcCtD
Desonide—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.00199	0.002	CcSEcCtD
Desonide—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.002	CcSEcCtD
Desonide—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00198	0.00199	CcSEcCtD
Desonide—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.00199	CcSEcCtD
Desonide—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00193	CcSEcCtD
Desonide—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00193	CcSEcCtD
Desonide—Rash pustular—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00189	CcSEcCtD
Desonide—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00186	CcSEcCtD
Desonide—Pharyngitis—Dactinomycin—peripheral nervous system neoplasm	0.00185	0.00186	CcSEcCtD
Desonide—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00184	0.344	CrCbGaD
Desonide—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00185	CcSEcCtD
Desonide—Sweating—Vincristine—peripheral nervous system neoplasm	0.00177	0.00178	CcSEcCtD
Desonide—Rash pustular—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00175	CcSEcCtD
Desonide—Cough—Topotecan—peripheral nervous system neoplasm	0.00174	0.00175	CcSEcCtD
Desonide—Cough—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00174	CcSEcCtD
Desonide—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00174	CcSEcCtD
Desonide—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Desonide—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00172	CcSEcCtD
Desonide—Cough—Melphalan—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Desonide—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00171	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00169	0.0017	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00168	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00168	CcSEcCtD
Desonide—Viral infection—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00167	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00165	0.00166	CcSEcCtD
Desonide—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00162	0.00163	CcSEcCtD
Desonide—Infection—Topotecan—peripheral nervous system neoplasm	0.00162	0.00163	CcSEcCtD
Desonide—Infection—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Desonide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Desonide—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.0016	0.00161	CcSEcCtD
Desonide—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Desonide—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Desonide—Infection—Melphalan—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Desonide—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Desonide—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Desonide—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Desonide—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Desonide—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Desonide—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Desonide—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Desonide—Viral infection—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00155	CcSEcCtD
Desonide—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00152	CcSEcCtD
Desonide—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Desonide—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Desonide—Infestation—Etoposide—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Desonide—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Desonide—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00149	CcSEcCtD
Desonide—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Desonide—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00144	CcSEcCtD
Desonide—Pain—Topotecan—peripheral nervous system neoplasm	0.00139	0.0014	CcSEcCtD
Desonide—Pain—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00139	CcSEcCtD
Desonide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00139	CcSEcCtD
Desonide—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00138	CcSEcCtD
Desonide—Pain—Melphalan—peripheral nervous system neoplasm	0.00136	0.00137	CcSEcCtD
Desonide—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Desonide—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00133	CcSEcCtD
Desonide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00132	CcSEcCtD
Desonide—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00132	CcSEcCtD
Desonide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00129	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Desonide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Desonide—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00121	0.00122	CcSEcCtD
Desonide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Desonide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.0012	CcSEcCtD
Desonide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Desonide—Infection—Vincristine—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Desonide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Desonide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Desonide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Desonide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Desonide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Desonide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00113	0.00114	CcSEcCtD
Desonide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Desonide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Desonide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Desonide—Rash—Topotecan—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Desonide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Desonide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Desonide—Cough—Etoposide—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Desonide—Headache—Topotecan—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Desonide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Desonide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Desonide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Desonide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Desonide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Desonide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Desonide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Desonide—Pain—Vincristine—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Desonide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Desonide—Rash—Melphalan—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Desonide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.001	0.00101	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00099	0.000996	CcSEcCtD
Desonide—Infection—Etoposide—peripheral nervous system neoplasm	0.00095	0.000955	CcSEcCtD
Desonide—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000942	0.000947	CcSEcCtD
Desonide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000929	0.000934	CcSEcCtD
Desonide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000924	0.000929	CcSEcCtD
Desonide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000892	0.000897	CcSEcCtD
Desonide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000876	0.000881	CcSEcCtD
Desonide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000877	CcSEcCtD
Desonide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.000871	CcSEcCtD
Desonide—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000857	0.16	CrCbGaD
Desonide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00085	0.000855	CcSEcCtD
Desonide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00084	0.000845	CcSEcCtD
Desonide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00084	0.000845	CcSEcCtD
Desonide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000833	0.000837	CcSEcCtD
Desonide—Pain—Etoposide—peripheral nervous system neoplasm	0.000818	0.000822	CcSEcCtD
Desonide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00081	0.000815	CcSEcCtD
Desonide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00081	CcSEcCtD
Desonide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.000791	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000782	CcSEcCtD
Desonide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000782	CcSEcCtD
Desonide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000772	0.000776	CcSEcCtD
Desonide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000771	0.000776	CcSEcCtD
Desonide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000767	0.000771	CcSEcCtD
Desonide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000753	CcSEcCtD
Desonide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000749	CcSEcCtD
Desonide—Rash—Vincristine—peripheral nervous system neoplasm	0.000744	0.000748	CcSEcCtD
Desonide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000743	0.000747	CcSEcCtD
Desonide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000747	CcSEcCtD
Desonide—Headache—Vincristine—peripheral nervous system neoplasm	0.000739	0.000743	CcSEcCtD
Desonide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000696	CcSEcCtD
Desonide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000691	CcSEcCtD
Desonide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000683	CcSEcCtD
Desonide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000676	0.00068	CcSEcCtD
Desonide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000661	0.000664	CcSEcCtD
Desonide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000658	0.000662	CcSEcCtD
Desonide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000657	0.000661	CcSEcCtD
Desonide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00066	CcSEcCtD
Desonide—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000655	0.122	CrCbGaD
Desonide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000632	CcSEcCtD
Desonide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000611	0.000615	CcSEcCtD
Desonide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000611	CcSEcCtD
Desonide—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000604	0.113	CrCbGaD
Desonide—Rash—Etoposide—peripheral nervous system neoplasm	0.000603	0.000606	CcSEcCtD
Desonide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000602	0.000605	CcSEcCtD
Desonide—Headache—Etoposide—peripheral nervous system neoplasm	0.000599	0.000602	CcSEcCtD
Desonide—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000592	0.11	CrCbGaD
Desonide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000576	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000555	0.000558	CcSEcCtD
Desonide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000535	CcSEcCtD
Desonide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000533	CcSEcCtD
Desonide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000528	CcSEcCtD
Desonide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000523	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000521	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000516	CcSEcCtD
Desonide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000495	CcSEcCtD
Desonide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000489	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000484	CcSEcCtD
Desonide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000482	CcSEcCtD
Desonide—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000462	0.0862	CrCbGaD
Desonide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000461	CcSEcCtD
Desonide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000426	CcSEcCtD
Desonide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000381	CcSEcCtD
Desonide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000353	CcSEcCtD
Desonide—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000344	0.0642	CrCbGaD
Desonide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00034	CcSEcCtD
Desonide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000339	CcSEcCtD
Desonide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000338	CcSEcCtD
Desonide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000314	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000314	CcSEcCtD
Desonide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000312	CcSEcCtD
